Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENTECAVIR for Chronic hepatitis b: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 705 adverse event reports in the FDA FAERS database where ENTECAVIR was used for Chronic hepatitis b.

Most Reported Side Effects for ENTECAVIR

Side Effect Reports % Deaths Hosp.
Drug resistance 312 7.0% 9 61
Death 298 6.6% 290 27
Drug ineffective 207 4.6% 22 32
Hepatitis b 166 3.7% 64 17
Off label use 129 2.9% 10 36
Maternal exposure during pregnancy 126 2.8% 5 8
Viral mutation identified 121 2.7% 3 8
Renal impairment 118 2.6% 1 38
Pathogen resistance 115 2.6% 2 12
Fatigue 108 2.4% 6 16
Hepatic cancer 94 2.1% 28 19
Hepatocellular carcinoma 94 2.1% 41 40
Hospitalisation 88 2.0% 3 75
Hepatic failure 86 1.9% 72 22
Drug dose omission 82 1.8% 0 4

Other Indications for ENTECAVIR

Hepatitis b (1,583) Product used for unknown indication (1,035) Antiviral prophylaxis (64) Hepatitis b reactivation (63) Hepatic cirrhosis (57) Hepatitis (49) Hepatitis viral (42) Hiv infection (42) Prophylaxis (42) Chronic hepatitis c (41)

Other Drugs Used for Chronic hepatitis b

TENOFOVIR DISOPROXIL (1,156) LAMIVUDINE (998) ADEFOVIR DIPIVOXIL (776) TENOFOVIR ALAFENAMIDE (679) PEGINTERFERON ALFA-2A (234) TENOFOVIR (187) TELBIVUDINE (153) ADEFOVIR (77) EMTRICITABINE\TENOFOVIR DISOPROXIL (34) PEGINTERFERON ALFA-2B (32)

Related Pages

ENTECAVIR Full Profile All Chronic hepatitis b Drugs ENTECAVIR Demographics ENTECAVIR Timeline